Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 27, 2023
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
Fri, March 24, 2023
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
[ Fri, Mar 24th 2023
] - WOPRAI
Ed Arce Reiterated (CDTX) at Strong Buy and Held Target at $120 on, Mar 24th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $120 on, Mar 24th, 2023.
Ed has made no other calls on CDTX in the last 4 months.
There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $100 on, Wednesday, March 8th, 2023
